Bridge Therapeutics, Inc. of BIRMINGHAM, AL, a company, filed a Form D amendment with the SEC on 2019-04-24. $2.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Kelley S Alton | Related Person | Birmingham, AL |
| David H Bergstrom | Related Person | Birmingham, AL |
| Diana Harshbarger | Related Person | Birmingham, AL |
| Elizabeth Kelley | Related Person | Birmingham, AL |
| Russell Kelley | Related Person | Birmingham, AL |
| Joseph Mullin | Related Person | Birmingham, AL |
| Tim Peara | Related Person | Birmingham, AL |
| James G Sullivan | Related Person | Birmingham, AL |
| Christopher Patrick Palutis | Director | Richmond, KY |
| Joseph Patrick Mullin | Director | New York, NY |
| Elizabeth Gregory Kelley | Director | Lucedale, MS |
| Jason Patrick Bailey | Director | Keller, TX |
| Timothy Grant Peara | Executive Officer | Asheville, NC |
| James Gregory Sullivan | Director | Birmingham, AL |
| James Gregory Sullivan | Executive Officer | Birmingham, AL |
| Joseph S Mullin | Director | Birmingham, AL |
| Joseph S Mullin | Executive Officer | Birmingham, AL |
| David H Bergstrom | Director | Birmingham, AL |
| Elizabeth G Kelley | Director | Birmingham, AL |
| Tim G Peara | Executive Officer | Birmingham, AL |
| James G Sullivan | Director | Birmingham, AL |
| James G Sullivan | Executive Officer | Birmingham, AL |
| Russell G Kelley | Promoter | Birmingham, AL |
| Diana H Harshbarger | Director | Birmingham, AL |
| Kelley S Alton | Director | Birmingham, AL |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-12-18 | D | $1.5M | $321K |
| 2019-03-08 | D/A | — | — |
| 2018-02-23 | D/A | — | — |
| 2018-02-22 | D | — | — |